• Je něco špatně v tomto záznamu ?

Antimicrobial and cytotoxic activity of (thio)alkyl hexopyranosides, nonionic glycolipid mimetics

P. Džubák, S. Gurská, K. Bogdanová, D. Uhríková, N. Kanjaková, S. Combet, T. Klunda, M. Kolář, M. Hajdúch, M. Poláková,

. 2020 ; 488 (-) : 107905. [pub] 20191228

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028540

Grantová podpora
NV16-32302A MZ0 CEP - Centrální evidence projektů

A series of 19 synthetic alkyl and thioalkyl glycosides derived from d-mannose, d-glucose and d-galactose and having C10-C16 aglycone were investigated for cytotoxic activity against 7 human cancer and 2 non-tumor cell lines as well as for antimicrobial potential on 12 bacterial and yeast strains. The most potent compounds were found to be tetradecyl and hexadecyl β-d-galactopyranosides (18, 19), which showed the best cytotoxicity and therapeutic index against CCRF-CEM cancer cell line. Similar cytotoxic activity showed hexadecyl α-d-mannopyranoside (5) but it also inhibited non-tumor cell lines. Because these two galactosides (18, 19) were inactive against all tested bacteria and yeast strains, they could be a target-specific for eukaryotic cells. On the other hand, β-D-glucopyranosides with tetradecyl (11) and hexadecyl (12) aglycone inhibited only Gram-positive bacterial strain Enterococcus faecalis. The studied glycosides induce changes in the lipid bilayer thickness and lateral phase separation at high concentration, as derived from SAXS experiments on POPC model membranes. In general, glucosides and galactosides exhibit more specific properties. Those with longer aglycone show high cytotoxicity and therefore, they are more promising candidates for cancer cell line targeted inhibition.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028540
003      
CZ-PrNML
005      
20211209131648.0
007      
ta
008      
210105s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.carres.2019.107905 $2 doi
035    __
$a (PubMed)32004953
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic.
245    10
$a Antimicrobial and cytotoxic activity of (thio)alkyl hexopyranosides, nonionic glycolipid mimetics / $c P. Džubák, S. Gurská, K. Bogdanová, D. Uhríková, N. Kanjaková, S. Combet, T. Klunda, M. Kolář, M. Hajdúch, M. Poláková,
520    9_
$a A series of 19 synthetic alkyl and thioalkyl glycosides derived from d-mannose, d-glucose and d-galactose and having C10-C16 aglycone were investigated for cytotoxic activity against 7 human cancer and 2 non-tumor cell lines as well as for antimicrobial potential on 12 bacterial and yeast strains. The most potent compounds were found to be tetradecyl and hexadecyl β-d-galactopyranosides (18, 19), which showed the best cytotoxicity and therapeutic index against CCRF-CEM cancer cell line. Similar cytotoxic activity showed hexadecyl α-d-mannopyranoside (5) but it also inhibited non-tumor cell lines. Because these two galactosides (18, 19) were inactive against all tested bacteria and yeast strains, they could be a target-specific for eukaryotic cells. On the other hand, β-D-glucopyranosides with tetradecyl (11) and hexadecyl (12) aglycone inhibited only Gram-positive bacterial strain Enterococcus faecalis. The studied glycosides induce changes in the lipid bilayer thickness and lateral phase separation at high concentration, as derived from SAXS experiments on POPC model membranes. In general, glucosides and galactosides exhibit more specific properties. Those with longer aglycone show high cytotoxicity and therefore, they are more promising candidates for cancer cell line targeted inhibition.
650    _2
$a buňky A549 $7 D000072283
650    _2
$a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
650    _2
$a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
650    _2
$a sacharidové sekvence $7 D002240
650    _2
$a buněčné linie $7 D002460
650    _2
$a proliferace buněk $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a Enterococcus faecalis $x účinky léků $7 D013293
650    _2
$a galaktosa $x chemická syntéza $x chemie $x farmakologie $7 D005690
650    _2
$a glykosidy $x chemická syntéza $x chemie $x farmakologie $7 D006027
650    _2
$a HCT116 buňky $7 D045325
650    _2
$a lidé $7 D006801
650    _2
$a buňky K562 $7 D020014
650    _2
$a lipidové dvojvrstvy $x chemie $7 D008051
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a molekulární struktura $7 D015394
650    _2
$a maloúhlový rozptyl $7 D053838
650    _2
$a difrakce rentgenového záření $7 D014961
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gurská, Soňa $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic. $7 xx0267298
700    1_
$a Bogdanová, Kateřina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic.
700    1_
$a Uhríková, Daniela $u Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32, Bratislava, Slovakia.
700    1_
$a Kanjaková, Nina $u Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32, Bratislava, Slovakia.
700    1_
$a Combet, Sophie $u Laboratoire Léon Brillouin (CEA/CNRS), CEA Saclay, 91191, Gif-sur-Yvette Cedex, France.
700    1_
$a Klunda, Tomáš $u Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, SK-845 38, Bratislava, Slovakia.
700    1_
$a Kolář, Milan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic.
700    1_
$a Hajdúch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic. Electronic address: marian.hajduch@upol.cz.
700    1_
$a Poláková, Monika $u Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, SK-845 38, Bratislava, Slovakia. Electronic address: Monika.Polakova@savba.sk.
773    0_
$w MED00001049 $t Carbohydrate research $x 1873-426X $g Roč. 488, č. - (2020), s. 107905
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32004953 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20211209131647 $b ABA008
999    __
$a ok $b bmc $g 1608875 $s 1119720
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 488 $c - $d 107905 $e 20191228 $i 1873-426X $m Carbohydrate research $n Carbohydr Res $x MED00001049
GRA    __
$a NV16-32302A $p MZ0
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace